Wilson's disease: 31P and 1H MR spectroscopy and clinical correlation

Neuroradiology

Volumn 52, Issue 11, 2010, Pages 977-985

  Sinha, Sanjib ^a   Taly, A B ^a   Ravishankar, S ^a   Prashanth, L K ^a   Vasudev, M K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

MR spectroscopy; MRI; Wilson's disease

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID; PHOSPHOLIPID DERIVATIVE; PHOSPHORUS;

ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; MALE; NERVE CELL LESION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHOLIPID MEMBRANE; PHOSPHOLIPID SYNTHESIS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TREATMENT DURATION; WILSON DISEASE;

BIOLOGICAL MARKERS; BRAIN CHEMISTRY; CELL MEMBRANE; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; PHOSPHOLIPIDS; PHOSPHORUS ISOTOPES; PROTONS; STATISTICS AS TOPIC;

EID: 78650186610     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-010-0661-1     Document Type: Article

References (23)

1. King AD, Walshe JM, Kendall BE et al (1996) Cranial MR changes in Wilson's disease. Am J Roentgenol 167(6):1579-1584
2. Saatci I, Topcu M, Baltaoglu FF et al (1997) MR findings in WD. Acta Radiol 38(2):250-258
3. Starosta-Rubinstein S, Young AB, Kluin K et al (1987) Clinical assessment of 31 patients with WD. Correlations with structural changes on MRI. Arch Neurol 44:365-370
4. Magalhaes AC, Caramelli P, Menezes JR et al (1994) Wilson's disease:MRI with clinical correlation. Neuroradiology 36(2):97-100
5. Sinha S, Taly AB, Ravishankar S, Prashanth LK, Venugopal KS, Arunodaya GR GR, Vasudev MK, Swamy HS (2006) Wilson's disease: Cranial MRI observations and clinical correlation. Neuroradiology 48(9):613-621
6. Roh JK, Lee TG, Wie BA, Lee SB, Park SH, Chang KH (1994) Initial and follow-up brain MRI findings and correlation with the clinical course in Wilson's disease. Neurology 44(6):1064-1068
7. Barker PB (2005) Fundamentals of MR spectroscopy. In: Gillard JH, Waldman AD, Barker PB (eds) Clinical MR neuroimaging: Diffusion, perfusion and spectroscopy, 1st edn. Cambridge University Press, Cambridge
8. Page RA, Davie CA, MacManus D et al (2004) Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease. Neurology 63(4):638-643
9. Alanen A, Komu M, Penttinen M, Leino R (1999) Magnetic resonance imaging and proton MR spectroscopy in Wilson's disease. Br J Radiol 72(860):749-756
10. Kraft E, Trenkwalder C, Then Bergh F, Auer DP (1999) Magnetic resonance proton spectroscopy of the brain in Wilson's disease. J Neurol 246(8):693-699
11. Arias-Mendoza F, Brown TR (2004) In vivo measurement of phosphorous markers of disease. Dis Markers 19(2-3):49-68
12. Rand SD, Prost R, Li SJ (1999) Proton MR spectroscopy of the brain. Neuroimaging Clin N Am 9(2):379-395
13. Sappey-Marinier D, Deicken RF, Fein G, Calabrese G, Hubesch B, Van Dyke C, Dillon WP, Davenport L, Meyerhoff DJ, Weiner MW (1992) Alterations in brain phosphorus metabolite concentrations associated with areas of high signal intensity in white matter at MR imaging. Radiology 183 (1):247-256
14. Vigneron DB, Nelson SJ, Murphy-Boesch J, Kelley DA, Kessler HB, Brown TR, Taylor JS (1990) Chemical shift imaging of human brain: Axial, sagittal, and coronal P-31 metabolite images. Radiology 177(3):643-649
15. Lenkinski RE, Holland GA, Allman T, Vogele K, Kressel HY, Grossman RI, Charles HC, Engeseth HR, Flamig D, MacFall JR (1988) Integrated MR imaging and spectroscopy with chemical shift imaging of P-31 at 1.5 T: Initial clinical experience. Radiology 169(1):201-206
16. Stanley JA, Pettegrew JW, Keshavan MS (2000) Magnetic resonance spectroscopy in schizophrenia: Methodological issues and findings-part I. Biol Psychiatry 48(5):357-368
17. Prashanth LK, Sinha S, Taly AB, Vasudev MK (2010) Do MRI Features distinguish Wilson's disease from other early onset extrapyramidal disorders? An analysis of 100 cases. Movement Disorder (in press)
18. Prashanth LK, Taly AB, Sinha S et al (2005) Prognostic factors in patients presenting with severe neurological forms of Wilson's disease. QJ Med 98:557-563
19. Sinha S, Taly AB, Prashanth LK, Ravishankar S, Arunodaya GR, VasudevMK (2007) SequentialMRI changes inWilson's disease with De-coppering therapy: A study of 50 patients. Br J Radiol 80:744-749
20. Van Den Heuvel AG, Van der Grond J, Van Rooij LG, Van Wassenaer-van Hall HN, Hoogenraad TU, Mali WP (1997) Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR spectroscopy. Radiology 2003(2):539-543
21. Lang PA, Schenck M, Nicolay JP et al (2007) Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 13(2):164-170
22. Jayasundar R, Sahani AK, Gaikwad S, Singh S, Behari M (2002) Proton MR spectroscopy of basal ganglia in Wilson's disease: Case report and review of literature. Magn Reson Imaging 20(1):131-135
23. Wender M, Szczech J, Hoffmann S (1993) Analysis of heavy metals content in the brain with the use of electron paramagnetic resonance in a clinically unusual case of hepato-lenticular degeneration. Neuropatol Pol 31(1-2):17-24